Curia Global, Inc.

Curia Global, Inc. is a leading contract research, development, and manufacturing organization (CRDMO) with extensive expertise in Active Pharmaceutical Ingredient (API) development and manufacturing. Founded in 1991 (formerly Albany Molecular Research Inc. – AMRI) and headquartered in Albany, New York, USA, Curia provides integrated pharmaceutical solutions for biotechnology companies and global pharmaceutical manufacturers from early discovery through commercial production.

The company offers comprehensive API services including medicinal chemistry, process research, analytical development, scale-up, highly potent active pharmaceutical ingredient (HPAPI) manufacturing, sterile fill-finish services, biologics development, and commercial manufacturing. Curia supports customers throughout the entire pharmaceutical lifecycle with advanced scientific expertise, flexible manufacturing capacity, and regulatory support.

Curia operates a global network of research and manufacturing facilities across the United States, Europe, and Asia, enabling efficient technology transfer and worldwide supply chain management. Its facilities comply with stringent international quality standards established by the US FDA, EMA, MHRA, and other leading regulatory authorities. Through continuous investment in innovation, automation, sustainability, and advanced manufacturing technologies, Curia has become a trusted global partner for pharmaceutical ingredient manufacturing. The company’s commitment to scientific excellence, customer collaboration, and operational reliability continues to support the development of innovative medicines for patients worldwide.